Opinion Video March 24, 2025 Panelists discuss how patients and caregivers at the late-line treatment stage commonly struggle with profound concerns about diminishing treatment options, increased uncertainty about prognosis, managing complex and often cumulative side effects, financial toxicity from years […]
Addressing the Most Common Concerns Patients and Caregivers Have in Late-Line RRMM Read More »
Opinion Video March 24, 2025 Panelists discuss how caregivers supporting loved ones with late-line relapsed/refractory multiple myeloma (RRMM) should prioritize both patient and self-care by establishing sustainable support systems, maintaining open communication with the health care team, educating themselves about
Supporting a Loved One Through Late-Line RRMM Read More »
Opinion Video March 24, 2025 Panelists discuss how multiple myeloma support resources range from formal organizations like the International Myeloma Foundation and Multiple Myeloma Research Foundation to online patient communities, hospital-based support groups, and specialized social media networks, with advice
Helpful Resources and Advice for Patients Facing Disease Progression Read More »
Opinion Video March 24, 2025 Panelists discuss how effective communication with medical teams in advanced multiple myeloma requires proactive strategies including preparing prioritized question lists before appointments, bringing a designated note-taking advocate to consultations, utilizing patient portals for nonurgent concerns,
Sharing Concerns With Your Medical Team in Late-Line RRMM Read More »
Opinion Video March 24, 2025 Panelists discuss how physician-patient conversations about newer multiple myeloma therapies have evolved to include detailed discussions of potential benefits (higher response rates, novel mechanisms of action) alongside unique toxicity profiles (cytokine release syndrome with immunotherapies,
Patients’ Experiences With Newer Therapies and Side Effects in Late-Line RRMM Read More »
Video content above is prompted by the following: What practical considerations should patients and caregivers be aware of when considering these therapies (e.g., hospital stays, eligibility, timing)? Source link Saad Usmani, MD
Practical Considerations for Therapies Considered by the Patient and Caregivers in RRMM Read More »
Video content above is prompted by the following: What is the current treatment landscape for patients who have late-line RRMM? Source link Saad Usmani, MD
Current Treatment Landscape for Late-Line RRMM Read More »
Video content above is prompted by the following: What does “late-line” relapsed/refractory multiple myeloma mean, and how is it determined that a patient is “late-line”? Source link Saad Usmani, MD
What is Late-Line RRMM and How is it Determined? Read More »
